Chengdu Kanghua Biological Products Co., Ltd. (SHE:300841)
China · Delayed Price · Currency is CNY 50.90
-1.84 (-3.49%)
Sep 2, 2026, 3:04 PM CST
SHE:300841 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 1,219 | 1,165 | 1,432 | 1,577 | 1,447 | 1,292 |
Revenue Growth | 3.81% | -18.64% | -9.22% | 9.03% | 11.94% | 24.44% |
Gross Profit Gross Profit Growth | 1,098 | 1,064 | 1,347 | 1,472 | 1,345 | 1,207 |
Operating Income Operating Income Growth | 291.63 | 246.29 | 531.64 | 600.49 | 611.84 | 613.96 |
Net Income Net Income Growth | 246.53 | 219.9 | 398.65 | 509.22 | 598.07 | 829.48 |
Earnings Per Share EPS Growth | 1.90 | 1.69 | 3.03 | 3.81 | 4.46 | 6.16 |
EPS Growth | 19.48% | -44.11% | -20.47% | -14.71% | -27.57% | 78.42% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Biological Products Biological Products Growth | 1,165 | 1,326 | 1,577 | 1,442 | - |
Others Others Growth | 0.09 | 106.14 | 0.47 | 0.72 | 0.07 |
Total Total Growth | 1,165 | 1,432 | 1,577 | 1,447 | 1,292 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 1,033 | 1,151 | 1,001 | 1,039 | 651.46 | 926.88 |
Total Debt Total Debt Growth | - | 139.9 | 186.89 | 190.91 | 126.35 | 0.9 |
Net Cash (Debt) Net Cash Growth | 1,033 | 1,011 | 814.44 | 848.45 | 525.11 | 925.98 |
Net Cash Growth | 45.18% | 24.15% | -4.01% | 61.58% | -43.29% | -31.18% |
Net Cash Per Share Net Cash Per Share Growth | 7.95 | 7.78 | 6.19 | 6.34 | 3.92 | 6.88 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 475.89 | 379.71 | 572.24 | 573.98 | 194.99 | 130.33 |
Capital Expenditures CapEx Growth | -50.36 | -70.79 | -144.3 | -157.27 | -419.23 | -314.94 |
Free Cash Flow Free Cash Flow Growth | 425.53 | 308.92 | 427.94 | 416.71 | -224.24 | -184.61 |
Free Cash Flow Growth | 25.11% | -27.81% | 2.70% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 90.08% | 91.34% | 94.09% | 93.35% | 92.96% | 93.37% |
Operating Margin | 23.91% | 21.14% | 37.13% | 38.07% | 42.29% | 47.50% |
Pretax Margin | 24.04% | 22.30% | 32.62% | 36.39% | 47.26% | 70.84% |
Profit Margin | 20.22% | 18.88% | 27.84% | 32.28% | 41.34% | 64.18% |
FCF Margin | 34.89% | 26.52% | 29.89% | 26.42% | -15.50% | -14.28% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.500 | 0.500 | 1.000 | 2.000 | 0.500 | 1.000 |
Dividend Per Share Growth | -50.00% | -50.00% | -50.00% | 300.00% | -50.00% | 49.99% |
Dividend Yield | 0.89% | 0.70% | 1.89% | 2.74% | 0.63% | 0.76% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 27.80 | 42.70 | 17.54 | 20.37 | 18.92 | 23.08 |
Forward PE | 25.36 | 16.18 | 9.79 | 15.93 | 8.63 | 25.46 |
P/FCF Ratio | 16.11 | 30.40 | 16.34 | 24.89 | - | - |
PS Ratio | 5.62 | 8.06 | 4.88 | 6.58 | 7.82 | 14.81 |